Novartis Taiwan: Reimagining Medicine, Advancing Health Equity
With groundbreaking therapies and deep collaboration across Taiwan’s healthcare system, Novartis Taiwan is driving innovation, advancing equity, and building a healthier future.
pharmaceutical
The Limitless Potential of Repurposed Drugs
Drug repurposing revitalizes existing drugs for new uses, offering faster, affordable medical solutions. Taiwan is emerging as a leader in this innovative approach, with treatments like aspirin for heart health and remdesivir for Covid-19.
Eli Lilly’s Visionary Approach to Alzheimer’s and Chronic Weight Management
Eli Lilly is advancing treatments in oncology, diabetes, immunology, obesity, and Alzheimer’s disease, with new therapies on the horizon. In Taiwan, Lilly is addressing growing concerns about dementia and obesity with significant R&D investment and plans to conduct over 60 clinical trials in 2024.
Investing in Health, in Sync With International Standards
Taiwan’s National Health Insurance (NHI) system has long been a source of pride for Taiwan. However, the healthcare environment faces severe challenges due to long-term underinvestment and the significant increase in demand resulting from an aging population. The healthcare industry is confronted with serious shortages of medication, healthcare professionals, and investment. In 2023, the International…
Meet Jae Yeon Choi of MSD
Managing Director of MSD Taiwan Jae Yeon Choi’s career took a sudden turn when she interviewed for a position in the pharmaceutical industry. Choi immediately knew she had found the right place and has for the last two decades been dedicated to improving the industry, first in Korea and since 2020 in Taiwan. Choi’s biggest…
Taiwan Pushes Ahead with Domestic Vaccines
More than two million doses of Medigen’s MVC-COV1901 have been administered domestically, but it has yet to gain traction internationally. Meanwhile UBI Pharma’s UB-612 is pending emergency-use authorization in Taiwan. Early in the coronavirus pandemic, Taiwan made a fateful decision: It would develop its own COVID-19 vaccines and make them a key part of its…
Meet Elbert Man of Bristol Myers Squibb
Bristol Myers Squibb (BMS) Taiwan General Manager Elbert Man’s people-centric outlook on life and work is a perfect match for the pharmaceutical industry. Man emphasizes transparency, respect for boundaries, and healthy debate as essential to fostering high-performing teams, a philosophy that has helped him advance through several country manager roles at international pharma companies. Outside…
Bayer Leads Breakthrough Innovations in Health and Agriculture
“The confluence of biology, chemistry, and data sciences provides the opportunity to solve some of the world’s greatest challenges. But this opportunity only exists for companies and scientists who dare to ask, ‘what if.’” Those were the words of Werner Baumann, chairman of the Board of Management of Bayer AG, when he opened the company’s…
Meet Cellina Yeh of Pfizer
Pfizer Taiwan Country Manager Cellina Yeh says that her career of more than 30 years has been marked by a pattern: the offer of a new position every few years and her initial reluctance to accept it. Nevertheless, intrinsic motivation, curiosity, and an insistence on pushing herself outside of her comfort zone have brought Yeh…
Pfizer Gears up for Life-changing Breakthroughs
In the 60 years since Pfizer set up its first factory in Taiwan, the company has relentlessly pursued life-changing pharmaceutical and biotechnological breakthroughs. The company’s most important accomplishment in Taiwan, however, is its contribution to improving patients’ quality of life through the introduction to the market of the most advanced, innovative drugs, notes Country Manager…